NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod By: TalkMarkets June 23, 2017 at 11:00 AM EDT This week’s highlights include positive data from Novartis while the FDA approved a couple of attention deficit hyperactive disorder (ADHD) drugs. Read More >> Related Stocks: Bristol-Myers Squibb Merck & Co Neos Therapeutics Novartis Ag ADR Novo Nordisk A/S ADR Roche Holding AG Basel American Depositary Shares Shire Plc Ads